Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This study was 8 weeks randomized, double-blind trail to assess the effect of mirtazapine
versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients in 80
patients. Participants were assessed at baseline, 4 weeks and 8 weeks. Subject were
randomized to receive either mirtazapine 15 mg tablet daily or megestrol acetate 160 mg
tablet daily for 8 weeks. The primary outcome was the measure of FAACT(A/C) score and the
secondary measure includes weight, BMI, quality of life and evaluate adverse effects.
Phase:
Phase 2
Details
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh